Tina Vilsbll has served on scientific advisory panels, been part of speakers bureaus for, served as a consultant to, and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gilead, Mundipharma, MSD/Merck, Novo Nordisk, Sanofi, and Sun Pharmaceuticals
Lessening of hyperpigmentation, melasma and sun-induced dark spots
The core business model of most Indian GLP-1 startups follows a familiar SaaS playbook: subscription lock-in with a high churn risk masked as a "program." Pricing ranges from 6,000 to 30,000 per month depending on BMI bracket and program tier
Practical strategies include liquid diets, gastric ultrasound, and regional anaesthesia where appropriate
In the event of a national shortage in which Mounjaro is commercially unavailable according to the FDA, your physician may recommend compounded tirzepatide (the active ingredient in Mounjaro ) as an alternative treatment option.* *Mounjaro is not a weight loss drug